|
FY2025
12 months to Oct 31, 2025
|
FY2024
12 months to Oct 31, 2024
|
FY2023
12 months to Oct 31, 2023
|
FY2022
12 months to Oct 31, 2022
|
FY2021
12 months to Oct 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of debt issuance costs | |||||
| Stock-based compensation expense | |||||
| Deferred income taxes | |||||
| Gain on sale of assets | |||||
| Impairment charges | |||||
| Net Loss (Gain) on sale of business | |||||
| Other non-cash adjustments | |||||
| Loss on investment in China JV | |||||
| Changes in operating assets and liabilities, net | |||||
| Receivables, net | |||||
| Inventories, net | |||||
| Other current assets | |||||
| Accounts payable | |||||
| Accrued warranty | |||||
| Customer advances | |||||
| Other liabilities | |||||
| Long-term assets | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of property, plant and equipment | |||||
| Proceeds from sale of assets | |||||
| Proceeds from sale of businesses | |||||
| Other investing activities | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Net payments from borrowings on revolving credit | |||||
| Payment of dividends | |||||
| Repurchase and retirement of common stock | |||||
| Proceeds from exercise of common stock options | |||||
| Payments of withholding taxes for vesting of stock awards | |||||
| Other financing activities | |||||
| Net cash used in financing activities | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
| Supplemental disclosures of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net | |||||
| Cash paid for operating lease liabilities | |||||
| Operating right-of-use assets obtained | |||||
Loading...